Literature DB >> 4118560

Inhibition of insulin release by diphenylhydantoin and diazoxide in a patient with benign insulinoma.

M S Cohen, R H Bower, S M Fidler, R E Johnsonbaugh, J Sode.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4118560     DOI： 10.1016/s0140-6736(73)91251-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Phenytoin partially antagonized L-type Ca2+ current in glucagon-secreting tumor cells (ITC-1).

Authors:  T Miyazaki; T Hashiguchi; M Hashiguchi; S Sakai; T Tosaka; M Kanazawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

Review 2.  Pancreatic neuroendocrine tumors.

Authors:  Shailesh V Shrikhande; Bhawna Sirohi; Mahesh Goel; Savio G Barreto
Journal:  Indian J Gastroenterol       Date:  2012-10-03

3.  Effect of diazoxide or glucagon on hepatic glucose production rate during extreme neonatal hypoglycaemia.

Authors:  A Mehta; R Wootton; K N Cheng; P Penfold; D Halliday; T E Stacey
Journal:  Arch Dis Child       Date:  1987-09       Impact factor: 3.791

4.  Effect of diphenylhydantoin on patterns of insulin secretion in obese subjects.

Authors:  B Draznin; D Ayalon; E Hoerer; Z Oberman; A Harell; R Ravid; L Laurian
Journal:  Acta Diabetol Lat       Date:  1977 Jan-Apr

5.  Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia.

Authors:  A Aynsley-Green; J M Polak; S R Bloom; M H Gough; J Keeling; S J Ashcroft; R C Turner; J D Baum
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.